欢迎来到上海通蔚!

021-54845833/15800441009

品质保证 · 通蔚试剂

当前位置: 首页 > 科研产品 > 科研抗体 > 一抗 > 兔抗SPACA3多克隆抗体

产品中心

  • 兔抗SPACA3多克隆抗体

    规格:
    数量:

    购买数量

    价格:
    • 品牌 : 通蔚生物
    • 目录号 : TW22398
    • 应用 : 仅供科研使用
    • 保存条件 : 低温保存
    • 货期 : 现货
    • 商品库存:75
  • 商品详情
  • 参考文献
  • 说明书下载
  • 商品评论0
  • 相关产品



中文名称: 兔抗SPACA3多克隆抗体

英文名称: Anti-SPACA3 rabbit polyclonal antibody

别      名: CT54; LYC3; LYZL3; SLLP1; ALLP17; 1700025M08Rik

抗      原: SPACA3

相关类别: 一抗

储      存: 冷冻(-20℃)

宿      主: Rabbit

反应种属: Human

标  记 物: Unconjugate

克隆类型: rabbit polyclonal

技术规格

Background:

SPACA3 (sperm acrosome associated 3), also known as sperm lysozyme-like protein 1, lysozyme-like protein 3, lysozyme-like acrosomal sperm-specific secretory protein ALLP-17, cancer/testis antigen 54 (CT54), LYC3, SPRASA or LYZL3, is a 215 amino acid protein that participates in the fusion and adhesion of sperm and egg plasma membrane during fertilization. Identified as a novel cancer/testis antigen in hematologic malignancies, SPACA3 has the ability to elicit B-cell immune responses in patients with cancer and is considered a potential target for immunotherapy. A member of the glycosyl hydrolase 22 family which is expressed in testis, placenta and epididymis, SPACA3 exists as two alternatively spliced isoforms; SPACA3 isoform 1 is a single-pass type II membrane protein of the sperm acrosome whereas SPACA3 isoform 2 is a secreted protein. Sperm surface membrane protein that may be involved in sperm-egg plasma membrane adhesion and fusion during fertilization. It could be a potential receptor for the egg oligosaccharide residue N-acetylglucosamine, which is present in the extracellular matrix over the egg plasma membrane. The processed form has no detectable bacteriolytic activity in vitro.

Applications:

ELISA, IHC

Name of antibody:

SPACA3

Immunogen:

Full length fusion protein

Full name:

sperm acrosome associated 3

Synonyms:

CT54; LYC3; LYZL3; SLLP1; ALLP17; 1700025M08Rik

SwissProt:

Q8IXA5

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human thyroid cancer

IHC Recommend dilution:

30-150